| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |